CoChat

Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review

Open access
Syrowatka, Ania, Song, Wenyu, Amato, Mary G, Foer, Dinah, Edrees, Heba, Co, Zoe, Kuznetsova, Masha, Dulgarian, Sevan, Seger, Diane L, Simona, Aurélien, Bain, Paul A, Purcell Jackson, Gretchen, Rhee, Kyu, Bates, David W · 2022 · The Lancet Digital Health
Cited by 94

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Adverse drug events (ADEs) represent one of the most prevalent types of health-care-related harm, and there is substantial room for improvement in the way that they are currently predicted and detected. We conducted a scoping review to identify key use cases in which artificial intelligence (AI) could be leveraged to reduce the frequency of ADEs. We focused on modern machine learning techniques and natural language processing. 78 articles were included in the scoping review. Studies were heterogeneous and applied various AI techniques covering a wide range of medications and ADEs. We identified several key use cases in which AI could contribute to reducing the frequency and consequences of ADEs, through prediction to prevent ADEs and early detection to mitigate the effects. Most studies (73 [94%] of 78) assessed technical algorithm performance, and few studies evaluated the use of AI in clinical settings. Most articles (58 [74%] of 78) were published within the past 5 years, highlighting an emerging area of study. Availability of new types of data, such as genetic information, and access to unstructured clinical notes might further advance the field.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2589-7500(21)00229-6

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 94

Metadata

Authors
Syrowatka, A., Song, W., Amato, M. G., Foer, D., Edrees, H., Co, Z., Kuznetsova, M., Dulgarian, S., Seger, D. L., Simona, A., Bain, P. A., Purcell Jackson, G., Rhee, K., & Bates, D. W.
Venue
The Lancet Digital Health
Publisher
Elsevier BV
Published
2022-02
Volume
4
Issue
2
Pages
e137-e148
ISSN
2589-7500 (ISSN-L)
OpenAlex
W3217124584
Cited by
94
References
4
FWCI
27.09
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review. https://app.cochat.ai/papers/10.1016/s2589-7500(21)00229-6
The paper
Syrowatka, A., Song, W., Amato, M. G., Foer, D., Edrees, H., Co, Z., Kuznetsova, M., Dulgarian, S., Seger, D. L., Simona, A., Bain, P. A., Purcell Jackson, G., Rhee, K., & Bates, D. W. (2022). Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review. The Lancet Digital Health. https://doi.org/10.1016/s2589-7500(21)00229-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.